When was Cytokinetics founded?

Cytokinetics was founded in 1997 and raised its 1st funding round 2 years after it was founded.

Where is Cytokinetics located?

Cytokinetics is headquartered in San Francisco, United States. It is registered at South San Francisco, California.

How many employees does Cytokinetics have?

As of Apr 30, 2026, the latest employee count at Cytokinetics is 765.

Is Cytokinetics a funded company?

Cytokinetics is a funded company, having raised a total of $60M across 11 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Oct 12, 1999.

When was the latest funding round of Cytokinetics?

Cytokinetics' latest funding was a $***** Post IPO round on Jul 01, 2022, with participation from 0 investor.

What is the annual revenue of Cytokinetics?

Annual revenue of Cytokinetics is $88M as on Dec 31, 2025.

Where does Cytokinetics rank among its competitors?

Cytokinetics ranks 2nd amongst 47 active competitors, of which 15 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Epicrispr Bio, which secured $68M in Mar, 2025.

Who are the top competitors of Cytokinetics?

Cytokinetics' top competitors include AskBio, Epicrispr Bio and BioAge Labs. Among them, Epicrispr Bio secured the most recent funding round in March, 2025.

Cytokinetics - 2026 Company Profile, Funding, Competitors & Financials

Company Details

Developer of muscle activators as potential treatments for debilitating diseases. Its drug pipeline includes Omecamtiv mecarbil, a novel activator of cardiac myosin, the motor protein that powers cardiac muscle contraction and is being investigated as a potential treatment for heart failure in collaboration with Amgen. Also developing CK-2127107 (CK-107), a novel skeletal muscle troponin activator as a potential treatment for people living with spinal muscular atrophy (SMA).

Website: cytokinetics.com
Social
Registered Address: South San Francisco, California

Key Metrics

Founded Year

1997

Location

San Francisco, United States

Stage

Public

Total Funding

$60M in 11 rounds

Latest Funding Round

Post IPO, Jul 01, 2022, $*****

Investors

Vulcanventuresinvestments.com & 13 more

Ranked

2^nd among 47 active competitors

Annual Revenue

$88M as on Dec 31, 2025

Employee Count

765 as on Apr 30, 2026

Investment & Acquisitions

Imbria Pharmaceuticals

Similar Companies

AskBio & 50 more

Exit Details

Public

View Cytokinetics' full profile

Cytokinetics is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Cytokinetics Inc CIN: 1061983 , United States, Deadpooled	Aug 04, 1997	$88M (As on Dec 31, 2025)	-	-
Cytokinetics, Incorporated CIN: 94-3291317 , United States, Active	Aug 04, 1997	-	423 (As on Dec 31, 2023)	-
Cytokinetics, Inc. CIN: 943291317 , United States, Active	Dec 26, 999	-	485 (As on Dec 31, 2024)	-

Cytokinetics got listed on Apr 29, 2004.

Click here to take a look at Cytokinetics's IPO in detail

Cytokinetics has raised a total funding of $60M over 11 rounds. Its first funding round was on Oct 12, 1999. Cytokinetics has 14 institutional investors.

Here is the list of recent funding rounds of Cytokinetics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 01, 2022	4763357	Post IPO	4482919	7712558	8032053	7274922
Jul 14, 2020	1966291	Post IPO	2455782	6762034	6707443	4210684
Nov 07, 2019	8820849	Post IPO	9626701	4881296	4026624	7317224

Access funding benchmarks and valuations. Sign up today!

View details of Cytokinetics's funding rounds and investors

Cytokinetics' employee count trend

Cytokinetics has 765 employees as of Apr 26. Here is Cytokinetics's employee count trend over the years:

Uncover Cytokinetics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cytokinetics include AskBio, Epicrispr Bio and BioAge Labs. Here is the list of Top 10 competitors of Cytokinetics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AskBio 2001, Durham (United States), Acquired	Developer of AAV technologies for treating genetic and complex disorders	$235M	Vida Ventures, TPG & 4 others	68/100
2nd	Cytokinetics 1997, San Francisco (United States), Public	Developer of muscle activators as potential treatments for debilitating diseases	$60M	Amgen Business Development, Deerfield & 12 others	68/100
3rd	Epicrispr Bio 2018, San Francisco (United States), Series B	Developer of therapeutics for multiple disease	$68M	Ally Bridge Group, LDV Partners & 1 others	63/100
4th	BioAge Labs 2015, Vallejo (United States), Public	Provider of a bioinformatics platform for biomarkers and drug discovery	$294M	Andreessen Horowitz, Sofinnova Investments ... & 26 others	61/100
5th	VectoryTx 2020, Amsterdam (Netherlands), Series A	Developer of therapeutics for neurodegenerative and muscular disorder	$176M	Forbion, EQT & 6 others	61/100
6th	Solid Biosciences 2014, Cambridge (United States), Public	Developer of gene therapy platform for Duchenne muscular dystrophy	$92.5M	Bain Capital Life Sciences, RA Capital Management ... & 16 others	60/100
7th	Regenxbio 2008, Rockville (United States), Public	Developer of AAV Gene Therapy for rare genetic diseases	$108M	Brookside Capital, Venrock & 15 others	59/100
8th	Epirium Bio 2008, San Diego (United States), Series A	Developer of therapeutic solutions for the treatment of cancer patients	$85M	Longitude Capital, Arch Venture Partners & 5 others	58/100
9th	Biophytis 2006, Romainville (France), Public	Developer of drugs for neuromuscular and age-related diseases	$2.6M	Kreos Capital, Seventure Partners & 1 others	55/100
10th	Satellos Bioscience 2012, Toronto (Canada), Public	Developer of small molecule drugs for rare diseases	$1.1M	Parent Project Muscular Dystrophy, Qiming ... & 1 others	53/100